Lv11
100 积分 2022-11-29 加入
Precision treatment in advanced hepatocellular carcinoma
11小时前
待确认
Biomarkers for immunotherapy of hepatocellular carcinoma
12小时前
已完结
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
11天前
已完结
Prediction of Prognosis for cHCC-CC Patients After Surgery: Comparison of Tumor Marker Score Based on AFP, CEA, CA19-9, and Other Clinical Stages
1个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2个月前
已完结
Laparoscopic Glissonian pedicle versus hilar dissection approach hemihepatectomy: A prospective, randomized controlled trial
2个月前
已完结
Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance
4个月前
已完结
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
11个月前
已完结
Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study
1年前
已完结
Therapeutic developments in pancreatic cancer
1年前
已完结
皖公网安备34019202002308
